Market Tracker

02/23 5:15pm ET

Mesoblast Ltd (NASDAQ:MESO)

6.19
Delayed Data
As of Feb 23
 +0.11 / +1.81%
Today’s Change
4.74
Today|||52-Week Range
12.50
+5.99%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close6.08
Today’s open6.51
Day’s range6.08 - 6.51
Volume78,043
Average volume (3 months)44,442
Market cap$578.0M
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)-1,605.50%
Earnings growth (this year)+10.78%
Earnings growth (next 5 years)+24.00%
Revenue growth (last year)-95.31%
P/E ratioNM
Price/Sales322.85
Price/Book1.03

Competitors

 Today’s
change
Today’s
% change
IVCInvacare Corp-0.12-0.67%
RTIXRTI Surgical Inc+0.05+1.12%
SIENSientra Inc+0.27+2.91%
OFIXOrthofix Internation...-0.45-0.83%
Data as of 4:01pm ET, 02/23/2018

Financials

Last reporting dateFebruary 23, 2018
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$1.9M
Annual profit (last year)-$76.8M
Net profit margin-3,951.39%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, MD &
Executive Director
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts